References
- Hori M., Satoh S., Maibach H. I. Percutaneous Absorption, Chapter 13, R. L. Bronaugh, H. I. Maibach. Marcel Dekker, New York 1989; 197
- Loftsson T., Somogyi G., Bodor N. Acta Pharm. Nord. 1989; 1: 279
- Loftsson T., Gildersleeve N., Bodor N. Pharm. Res. 1987; 4: 436
- Bodor N., Loftsson T. Acta Pharm. Nord. 1990; 2: 123
- Cooper E. R. Transdermal Controlled Systemic Medications, Chapter 3, Y. W. Chien. Marcel Dekker, New York 1987; 83
- Szejtli J. Pharm. Tech. Int. 1991; 3(2)15
- Szejtli J. Pharm. Tech. Int. 1991; 3(3)16
- Loftsson T., Brewster M. E., Derendorf H., Bodor N. Pharm. Ztg. Wiss. 1991; 4/136: 5
- Pitha J., Milecki J., Fales H., Panell L., Uekama K. Int. J. Pharm. 1986; 29: 73
- Szejtli J. Cyclodextrin technology. Kluwer Acad. Publ., The Netherlands 1988
- Loftsson T., Ólafsdóttir S. J., Bodor N. Eur. J. Pharm. Biopharm. 1991; 37: 30
- Arima H., Adachi H., Irie T., Uekama K. Drug Invest. 1990; 2: 155
- Loftsson T. Arch. Pharm. Chemi, Sci. Ed. 1982; 10: 17